Loading...
XAMS
CRBN
Market cap1.26bUSD
Jul 22, Last price  
19.22EUR
1D
-0.98%
1Q
7.86%
Jan 2017
-24.42%
Name

Corbion NV

Chart & performance

D1W1MN
XAMS:CRBN chart
P/E
14.81
P/S
0.87
EPS
1.30
Div yield, %
3.33%
Shrs. gr., 5y
-0.51%
Rev. gr., 5y
5.14%
Revenues
1.27b
-1.61%
2,421,400,0002,485,600,0002,599,300,0002,555,900,0002,990,100,0003,112,600,000753,700,000743,600,000770,100,000918,300,000911,300,000891,700,000897,200,000976,400,000986,500,0001,070,800,0001,457,900,0001,443,800,0001,288,100,0001,267,400,000
Net income
75m
-61.08%
104,700,000202,800,00090,000,00086,800,00099,300,000-174,300,000-65,300,0002,400,000-20,700,00080,200,000103,600,00084,600,00054,300,00025,800,00073,100,00078,300,00090,000,00072,900,000192,200,00074,800,000
CFO
161m
-12.60%
177,800,000138,800,00098,500,000277,200,000188,600,000148,000,000197,400,0009,900,00066,800,000110,300,000122,600,000117,700,00099,500,000115,700,000113,400,00026,700,00053,200,000165,400,000184,100,000160,900,000
Dividend
May 15, 20261 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. It operates through the following segments: Food and Biochemicals. The Food segment provides biobased ingredients for the food industry. The Biochemicals segment produces chemicals derived from organic acids through the fermentation of carbohydrates, and lactic acid based solutions. The company was founded on August 21, 1919 and is headquartered in Amsterdam, the Netherlands.
URL
http://www.corbion.com/
IPO date
Jan 04, 1999
Employees
2,601
Domiciled in
NL
Incorporated in
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT